« Previous
Next »
Journal of Endodontics
Volume 33, Issue 11
, Pages 1319-1324
, November 2007
Localized Increases in Corticotropin-releasing Factor Receptors in Pulp after Dental Injury
References
- . Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc Natl Acad Sci U S A. 1981;78:6517–6521
- . Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and betaendorphin. Science. 1981;213:1394–1397
- . In vivo corticotropin-releasing factorinduced secretion of adrenocorticotropin, beta-endorphin, and corticosterone. Endocrinology. 1982;110:272–278
- . The role of pituitary betaendorphin in mediating corticotropin-releasing factor-induced antinociception. Am J Physiol. 1990;258(Pt 1):E235–E242
- . Release from inflamed tissue of a substance with properties similar to corticotropin-releasing factor. Neuroendocrinology. 1989;49:476–482
- . Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins. Nature. 1986;321:881–882
- Immune cell-derived beta-endorphin: roduction, release, and control of inflammatory pain in rats. J Clin Invest. 1997;100:142–148
- Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci U S A. 1990;87:5935–5939
- . Corticotropin releasing factor (CRF) has a peripheral site of action for antinociception. Eur J Pharmacol. 1989;170:275–279
- . Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci U S A. 1994;91:4219–4223
- . Involvement of corticotropin-releasing hormone receptor subtypes 1 and 2 in peripheral opioid-mediated inhibition of inflammatory pain. Pain. 2003;106:297–307
- . The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr Rev. 2006;27:260–286
- Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci U S A. 1994;91:8777–8781
- . Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology. 1995;20:789–819
- . mRNA expression profiles for corticotrophin-releasing factor (CRF), urocortin, CRF receptors and CRF-binding protein in peripheral rat tissues. J Mol Endocrinol. 2000;25:43–52
- . Immunocytochemical investigation of immune cells within human primary and permanent tooth pulp. Int J Paediatr Dent. 2006;16:2–9
- . Characterization of CD45 and CD45R monoclonal antibodies using transfected mouse cell lines that express individual human leukocyte common antigens. J Immunol. 1988;141:3910–3914
- . Local opioids in the inflamed dental pulp. J Endod. 2006;32:319–323
- . Immunohistochemical localization of muopioid receptors in human dental pulp. J Endod. 2003;29:108–110
- . Delta (delta) opioid receptors in small and medium-sized trigeminal neurons supporting the dental pulp of rats. Arch Oral Biol. 2006;51:273–281
- . Local upregulation of corticotropinreleasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation. Eur J Pharmacol. 1996;311:221–231
- . Immunohistochemical study on the immunocompetent cells of the pulp in human non-carious and carious teeth. Arch Oral Biol. 1995;40:609–614
- . Defense responses of dentin/pulp complex to experimentally induced caries in rat molars: an immunohistochemical study on kinetics of pulpal Ia antigen-expressing cells and macrophages. J Endod. 1997;23:115–120
- . Dental injury models: experimental tools for understanding neuroinflammatory interactions and polymodal nociceptor functions. Crit Rev Oral Biol Med. 1999;10:4–39
- Opioid peptide-expressing leukocytes: identification, recruitment, and simultaneously increasing inhibition of inflammatory pain. Anesthesiology. 2001;95:500–508
- . Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. Proc Natl Acad Sci U S A. 1996;93:6096–6100
- . Corticotropin-releasing factor (CRF) produces analgesia in humans and rats. Brain Res. 1987;422:154–157
- Analgesic effects of peripherally administered opioids in clinical models of acute and chronic inflammation. Clin Pharmacol Ther. 2001;70:66–73
- . Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience. 1993;55:185–195
- Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid-containing leukocytes but by opioid receptor expression. Pain. 2004;108:67–75
- . Basics of anesthesia. 4th ed.. New York: Churchill Livingstone; 2000;
- Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells. Pain. 2004;112:229–238
- . A double-blind comparison of a supplemental interligamentary injection of fentanyl and mepivacaine with 1:200,000 epinephrine for irreversible pulpitis. J Pain Symptom Manage. 2007;33:203–207
- . Influence of CRF and alpha-MSH on the migration of human monocytes in vitro. Neuropeptides. 1992;23:99–102
- Mechanisms underlying the anti-inflammatory actions of central corticotropin-releasing factor. Am J Physiol. 1999;276(Pt 1):G1016–G1026
PII: S0099-2399(07)00742-X
doi: 10.1016/j.joen.2007.08.009
© 2007 American Association of Endodontists. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Endodontics
Volume 33, Issue 11
, Pages 1319-1324
, November 2007
